NASDAQ OMX Derivatives Markets has carried out a re-calculation of options and futures in Novozymes (NZYMB) due to a split. For details regarding the re-calculation please see exchange notice 100/11.
Adjusted series have received an “X” in the series designation, and have also received new ISIN-codes.
For further informaion, please see the attached file.
